The researchers discovered that CD4 + Th1 cells, a type of immune cell, play a key role in targeting and eliminating dormant cancer cells. These cells, which can remain hidden in the body, have ...
Hosted on MSN10mon
Improving cancer immunotherapy by prolonging T-cell survivalTh1 cells can mount an anti-cancer response but are short-lived, while Th17 cells have greater longevity but are unable to mount a response. Combining the two harnesses the strengths of both ...
increased regulatory T cells while decreasing inflammatory TH1 and TH17 cells, highlighting MSCs' potential as a novel treatment to prevent ocular complications associated with GVHD. Graft-versus ...
Improper self-antigen recognition by DCs and T-cell initiates, through release of specific cytokines (as described above), destructive Th1 or Th2 responses. RA, for example, is characterized by an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results